Gelonghui May 27丨Heavy Pharmaceutical Holdings (000950.SZ) was surveyed by a specific target on May 27, 2024, on “This year's business plan?” The company replied that in 2024, the company will take root in its main business and accelerate the development of various business segments. At the same time, under comprehensive circumstances such as operating capacity and future development plans, it is expected to achieve annual revenue of 85-90 billion yuan.
重药控股(000950.SZ)：预计全年实现营业收入850-900亿元
Heavy Pharmaceutical Holdings (000950.SZ): Expected to achieve annual revenue of 85-90 billion yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.